the present invention features methods and pharmaceutical compositions for the treatment of hepatitis c in a human in need thereof comprising administering a compound of formula , , , , , or described herein or a pharmaceutically acceptable salt thereof in combination with one or more additional hepatitis c therapeutic agents .